The 7 important sections in an annual report

A company’s Annual Report is a statutory document that contains material facts and information about the company. This makes it among the most reliable sources for information on a company. For the analyst community, its importance has reduced over time due to regular management conference calls, results presentations, and the continuous stream of information during the year.

The 7 important sections in an annual report

But for investors who will find it harder to track such concalls (and who can’t generally participate in them either!), exchange announcements, and so on, the annual report is a valuable document to get insights on the company. This single document gives an investor access to both qualitative and quantitative information which helps in building a good understanding about the prospects of a company. There are even companies of respectable size that do not conduct regular con-calls, but give detailed insights into their business in their annual report. 

In this article, we will try to give examples of where in an annual report you can find information that is useful for your understanding of business and financials. 

Note: We had written an article on ‘How to read an annual report’ two years ago. Since this topic is an evergreen one, we have updated it with fresh examples to make it more relevant to these times.

Key sections of an annual report

  1. Chairman’s statement
  2. 10 Year financial highlights
  3. Management Discussion & Analysis
  4. Board’s report
  5. Corporate governance report
  6. Auditor’s Report
  7. Financial Statements

Here, we have broken down the annual report into different sections, explaining what information you can find in each and how it can be useful along with examples. We’ll start with qualitative information and then move to quantitative.

#1 Chairman’s Statement

It is a delicious starter to the wide menu of information that is inside. It gives quick insights on the company’s business and its future. In large business groups, this can be an excellent read. This assumes significance in the case of conglomerates and corporates where there may be significant changes happening which could lead to changes in the overall vision.

For example, for Ambuja Cement, the holding company for ACC as well, the Chairman’s statement from Gautam Adani carries a fresh view of aggression on growth. This was not the case with these companies in the past decade under an MNC ownership. The company was also seeking shareholder approval to infuse Rs.20,000 crore of fresh equity by the group through warrants despite being cash-rich, which also explains the aggression.

M&M Group now has a professional Chairman, Anish Shah, who has been leading the transformation at the group towards profitable growth with target RoCE of 18% across companies. In the case of M&M Financial, he talks about the broader vision, strategy as well as its CEO succession plan beginning FY24 as its long time CEO superannuates in April 2024.

#2 CEO comments/ Q&A

While the Chairman’s statement gives an overall direction, this part will contain the specifics of how the organization is planning to move forward. This also assumes significance in the case of organizations where there are changes underway.

For example, MNC United Spirits (Diageo India) along with unlisted Pernod Ricard owns a lion’s share (~80-85%) of India’s premium liquor market. United Spirits has been embarking on a strategy to undertake slump sale of its mass-market brands and has completed it during FY23. What is left is its premium portfolio of brands. The company gave a detailed Q&A section with its CEO in the annual report on its future strategy. 

Bharat Forge’s annual report carries the title “Tonnage and Technology” where the CMD explains how it is transforming from a forging company to a “products and systems” company with verticals such as defense, aerospace, and renewable energy as new focus. He talks about the major pivots that took place in 1990s, early 2000s and now in the 2020s.

#3 Board of Directors

Know the people behind a company when you are first looking up a company in an emerging growth sector, which can be valuable to boost confidence. There will be nominee directors represented by large private equity investors as well. This may open an additional avenue of information, by tracking the performance of companies they have invested in the past. Information such as this can also give some comfort on the kind of leadership and experience a company has access to.

Glance through the annual reports of many of the newly-listed companies and you will find a lot of nominee directors representing private equity investors on the board. But as of now, we are seeing PE players pressing the exit button on their remaining stake in these companies. It should be interesting to watch how the board composition changes from here on. 

For a different example, go to the “Board of Directors” section of Aptus Value Housing annual report – there are two nominee directors representing its major PE invest, Westridge Capital, in the company. Piramal Pharma, that was recently demerged and listed, has a nominee director from PE Carlyle.

Nominee directors will also be there in companies that are MNC associates. Take the case of Lumax Industries, a sub Rs.2,000 market cap company with Stanley Electric of Japan directly holding 37.5% stake. The company has a larger board compared to its size and has three nominee directors from Stanley Electric. The profile of Independent Directors is another important thing to look out for when you are looking to invest in smaller companies to build some comfort on the governance aspect.

#4 Management Discussion and Analysis

This section contains a good amount of data and reasoning behind a company’s performance for the year, what the company plans to do, industry, and so on. Based on the depth of the explanations provided in this section, it’s a veritable treasure chest of information. Typically, this section covers the following areas.

Structure of industry

This is in terms of the opportunity size, factors leading/ailing growth, competitive intensity, structural changes that have taken place and so on. This will give you the basics about the industry the company operates in, upon which you can build further through other sources. It makes it easier to understand the company’s performance as well.

Take the case of IT sector. In the last 6 months, we have seen was a complete divergence in earnings performance between mid-cap and large cap players. Most of them deliver specialized services and are an integral part of the transformation unfolding in automobile, industrial, media and telecom sectors.  

Similarly, auto sector is seeing a big change in terms of efficiency, driver information and premium features. Lighting, advanced driver information systems, sunroofs, etc. are finding wider acceptance. You can check annual reports of Lumax Industries, Pricol and Asahi Glass for more on these trends and how they will benefit. 

Electronics manufacturing has seen a flurry of IPOs recently. Starting with the prominent players such as Dixon and Amber, a reading of annual reports of the newly listed ones may provide an insight into the future of this sunrise industry. 

Consumption is another sector that is getting broad-based as well as where premiumization is taking off. The annual report of companies driving premiumization will be insightful to understand how the trend is shaping up.

Business growth

Business growth and factors that have led to growth, or reasons for slack in performance can be found in the MDA. This is specific to each company. It tells you steps the company took to drive growth, giving you an idea about sustainability of that growth. It explains the key events that led to that year’s performance as well. For any growing company, this part of the annual report may give insights to new engines of growth even if they are not separately reportable segments.  

For example, IT companies talk about their deal wins in terms of ‘Total Contract Value’ while engineering and capital goods companies or even defence players talk about their ‘Order Book’. You can take cues on how long the Order Book will last, how much it can translate into revenue by doing a rough match of Order Book to Sales or Book to Bill ratio etc. 

Even auto component companies have started to publish data on ‘New Order Wins’ for programs like EV which are new to their business. This gives a sense of whether they are gaining traction in new businesses.

Segment-wise information

This is given where companies have varied product/service basket. This helps understand which segment contributes more to growth and profitability and the focus areas for the company. 

Engineering player Greaves Cotton received a lot of attention for its diversification to EVs. A sub Rs.2,000 crore revenue company a few years ago, it has clocked Rs.1,000 crore revenue from EV business alone in FY23. This takes the center stage in this year’s annual report and has detailed outlay of its plans in this business.

Piramal Pharma, that saw a lackluster listing in the market post demerger, has released its first annual report. The company caught investor attention for its niche business segments. Its annual report is a must-read on both the qualitative and quantitative sides. The company has a lot of things to get right on both these sides to reward its shareholders.

Other details

Capital expenditure plans provide visibility on whether a company is investing for growth or not. Apart from conventional sectors, renewable energy is one area that is attracting significant capex on the supply side. Amara Raja Batteries has drawn an ambitious capex plan of Rs.9,500 crore in lithium battery manufacturing over an 8-9 year period. The company has given detailed insight into its structured and calibrated approach to this capex plan in its FY23 Annual report under a separate category “New Energy”. 

Acquisitions or other business transformation initiatives such as mergers, de-mergers, CEO changes, and so on. Sometimes, you may have to read annual reports for at least 3 years where companies have undergone a significant business transformation, to capture the change.  

As FMCG companies become a new home to lot of start-ups from the digital consumer space, Marico is one company that is trying to make big from it. Its new engines of growth such as foods, premium personal care and digital first brands are growing to contribute to 20% of its sales and has detailed takeaways in its annual report. Digital-first brands alone are growing twice or thrice as fast than its conventional business.

V-Guard, a south-based consumer durables player is on the verge of becoming a Rs.5,000 crore revenue company in FY24. For a company that has just around Rs.1,000 crore capital employed in business until FY20, the last 3 years has seen similar amount of fresh capital investment in domestic manufacturing and acquisitions. There is detailed discussion on these in its FY23 annual report and its future strategy.

It is important to take everything you read here with a pinch of salt. Remember that companies will tend to showcase their best performance and plans. Read Annual Reports for at least 3 years to see if the company has been delivering on what it has planned.

#5 Board’s Report

This statutory report provides information on areas including financial performance of subsidiary companies. There are two areas of interest here.

Management Remuneration: This is important in case of family-owned companies where the Board will comprise mainly family members. A check on this section becomes necessary where the promoter stake as well as dividend payout are low.  Such issues are less likely in larger companies due to shareholder activism, the rise of proxy advisory firms and tighter regulations recently. Mammoth ESOP rewards of new-age IPO companies have also come under the scanner of proxy advisory firms that advises institutions on voting on resolutions during AGM. Companies like Paytm, Eicher Motors, Bharat Forge, Apollo Tyres, etc. have faced attack from proxy advisory firms on management remuneration. The activism of proxy advisory firms seems to have brought in more rationality on this part. 

Related party transactions: This vouches for transparency of transactions between group companies. Related party transactions are not bad on their own, as companies with subsidiaries and associates often engage in several such transactions. But the nature of transactions and the amounts involved matters and where they are not transparent or without good reason, it will help flag governance issues. This is something important to watch in the case of business groups where there are many loss-making businesses at the group level. 

For example, the Tata group has been dependent on TCS for long for its capital needs. Since the promoters own a majority stake in TCS, they could take out the cash flows as dividends or buy-backs and then use the resources independently rather than indulging in any related party transactions. In case promoters don’t own majority stake, that is where related party transactions generally crop up.

Britannia Industries, though a well-run business, featured in the news several times over inter-corporate deposits with group companies such as Bombay Burmah and Bombay Dyeing.  Rating agencies have also flagged off this as a concern in Britannia. Recently, one of these companies had to take huge write-off post the bankruptcy filing of Go Airlines, a group venture. In the last three years, Britannia has refrained from this practice while paying out dividends as high as 160% and 112% of net profits in FY21 & FY22 while using debt/bonus debentures route for its own capital expenditure plans.  

A related party transaction that could take centre stage can be that of Maruti’s proposed acquisition of parent Suzuki Motor Corp’s Gujarat plant, which it announced recently. The board has just approved the proposal and is yet to decide the consideration. This proposal could come up for voting of shareholders in the AGM and Maruti is yet to release its FY23 annual report. The same plant was at the centre of controversy in 2014 while Maruti managed to convince shareholders then.

Now, let’s take the more quantitative sections in the annual report – primarily, the financial statements.

#6 Auditors’ Report

Auditors’ opinion on financial statements is expressed in this section. There will be separate audit reports on standalone and consolidated financial statements. If a company has material subsidiaries which contribute significantly to cashflows, check the opinion of statutory auditor with respect to disclosure of information on such subsidiaries. 

However, this section needs to be looked at only in the case of companies that are at the center stage of any controversies. For example, Adani Ports has been under the scanner as its auditor Deloitte issued a qualified opinion regarding the transaction with a few entities mentioned in the Hindenburg report. The Auditor issued a qualified opinion as it could not ascertain whether the entities were related parties or unrelated parties.

#7 Financial Statements

There will be both Standalone and Consolidated statements comprising Balance Sheet, Profit & Loss Account and Cash Flow Statement. While Balance Sheet and P&L will give summary of financial information, detailed information will be available in the Notes to Accounts or Schedules. This is the meat of the financial statements and offers insight into the company’s financials that you will not be able to get from the main P&L or balance sheet.

Below are a few examples of what you can look for in the Notes/schedules to Accounts:

Balance Sheet

There are specific instances which require a detailed check into annual reports. One is to get clarity on items such as “borrowings”. The second is on “investments” and the third is the break-up of items under “other liabilities”. A few examples will explain:

For example, Bharat Forge’s vision statement says the company is eyeing consolidated EBIDTA margins of 20% and RoCE of 20% in its Vision 2030 plan. Prima facie look at the balance sheet may appear like it has too much of debt and receivables in its balance sheet. A detailed check on the break-up of  borrowings throws light on various forms of debt including the ‘bill discounting” facilities availed by the company. These items must be adjusted to arrive at numbers on capital employed to calculate RoCE. 

Companies in similar business lines may have similar arrangements on the working capital side. If you read the latest financial statements of ACC, you may see sudden changes in cash and other financial assets. Only balance sheet schedules in annual report can provide detailed insights to those. The change in tenure of bank deposits as well as advance payment for procurement of coal (vs paying after purchasing earlier) has led to a change in these items.

Likewise, you may generally get a lumpy figure under “investments”. This may contain strategic investments in companies, other quoted investments, liquid investments in mutual funds, etc. For example, Bharat Forge and Amara Raja have made major strategic investments in EV and battery technology companies, respectively. These are strategic in nature and are grouped under “investments”. 

Likewise, fast fashion retailer Trent Ltd has classified its investment (49% stake) in Inditex (ZARA) and Massimo Dutti as financial investments and so not consolidated in its financials. 

Bajaj Holdings has close to Rs.10,000 crore investments in other listed companies outside its core investments. It has significant investment in blue chips such as ICICI, HDFC, Reliance, L&T, Infosys, Ultratech and unlisted National Stock Exchange.

Balance Sheet reading may also be extremely useful in case of defence PSUs. They operate under a model where Govt. gives them ‘milestone advances’, which then sets-off against final product purchase. While their balance sheet may appear bloated on ‘receivables’, advances are classified under ‘other liabilities’. One may have to look at both these items to understand the actual extent of receivables. Defence PSU majors are yet to publish their FY-23 annual reports.

Cash flow statement

This is an important statement to look at in the case of new-age companies (their annual reports are yet to be published). While they seem to be reducing the losses from their financial results, the cash flow statement may provide a better insight into how much cash they burn and how much they have in hand. So far only one company, Paytm, has signaled lower cash burn through a small buy-back of equity shares using cash in its balance sheet. Others are still on diversification and growth spree. 

A reading of the annual report combining their business plans, capital investment plans and cash flow statement may give a better sense of whether these companies are well-funded to carry out their growth plans without raising fresh capital in a difficult environment. 

Defence PSUs is another cohort where one should be keeping a close eye on the cash flow statement. Due to the long gestation of orders and dependence on budgetary allocation, cash flow statement assumes more significant than P&L.

Expense break-ups and other details

The notes to P&L also provide granular details of operating and other expenses, where the P&L would provide only the broad top-level expense outgo. While most of these items may be readily readable from stock screeners and databases, one may go deep into annual reports in case of lack of clarity.

This is only an illustrative article based on our reading of limited number of annual reports for FY23. The stocks mentioned here are not to be taken as our recommendations or our view on potential. Please check Prime Stocks for those we have a Buy call on.

More like this

1 thought on “The 7 important sections in an annual report”

  1. Hi Chandra,

    This is an excellent summary of key points in Annual Report. While I do basic reading of few points regarding the shares I hold, but now with this article, I will be able to focus more specifically.

    While this will help, what I (and may be most of other investors too) will miss is the such key points of major companies. Is it a good idea for PI to open another box to summarise such key points of major companies (say Nifty 50 companies to begin with) for information to all readers. Further the comments on such key points by PI could be another value addition.

    Thanks in advance.

Comments are closed.

Hold On

You are being redirected to another page,
it may take a few seconds.
Login to your account
OR

Become a PrimeInvestor!

Get stock & mutual fund recommendations

Start registration

Start registration

OR
user icon
user icon
user icon

Terms & Conditions

A copy of the T&C has been sent to your email.

Last modified on February 18, 2025

This website www.primeinvestor.in (“Website”) is owned and operated by PrimeInvestor Financial Research Pvt. Ltd. (“RA”), a SEBI-registered Research Analyst with Registration No. INH200008653.

Through the Website, the RA allows clients to access research recommendations, research reports, and model portfolios, along with tools, personal finance products, and articles, on the payment of a subscription fee (“Research Services”). The terms ‘RA’ or ‘us’ or ‘we’ refer to PrimeInvestor Financial Research Pvt Ltd (SEBI RA Registration No INH200008653) who are the owners of this Website and offering the Research Services. The term ‘you’ and ‘client’ refers to the subscriber of the Services on the Website. The RA provides the Research Services subject to the notices, terms, and conditions set forth in these Terms. By accepting these Terms when you subscribe to the Research Services, you provide your consent to abide by these Terms.

Most Important Terms and Conditions (MITC)

[Forming part of the Terms and Conditions for providing research services]

  1. These terms and conditions, and consent thereon are for the research services provided by the Research Analyst (RA) and RA cannot execute/carry out any trade (purchase/sell transaction) on behalf of the client. Thus, the clients are advised not to permit RA to execute any trade on their behalf.
  2. The fee charged by RA to the client will be subject to the maximum amount prescribed by SEBI/ Research Analyst Administration and Supervisory Body (RAASB) from time to time (applicable only for Individual and HUF Clients).
    Note:
    • SEBI's current cap on fee is Rs 1,51,000/- per annum per family of client for all research services of the RA.
    • The fee limit does not include statutory charges.
    • The fee limits do not apply to a non-individual client / accredited investor.
  3. RA may charge fees in advance if agreed by the client. Such advance shall not exceed the period stipulated by SEBI; presently it is one quarter. In case of pre-mature termination of the RA services by either the client or the RA, the client shall be entitled to seek refund of proportionate fees only for the unexpired period.
  4. Fees to RA may be paid by the client through any of the specified modes like cheque, online bank transfer, UPI, etc. Cash payment is not allowed. Optionally the client can make payments through Centralized Fee Collection Mechanism (CeFCoM) managed by BSE Limited (i.e. currently recognized RAASB).
  5. The RA is required to abide by the applicable regulations/ circulars/ directions specified by SEBI and RAASB from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. The RA will endeavor to promptly inform the client of any conflict of interest that may affect the services being rendered to the client.
  6. Any assured/guaranteed/fixed returns schemes or any other schemes of similar nature are prohibited by law. No scheme of this nature shall be offered to the client by the RA.
  7. The RA cannot guarantee returns, profits, accuracy, or risk-free investments from the use of the RA's research services. All opinions, projections, estimates of the RA are based on the analysis of available data under certain assumptions as of the date of preparation/publication of research report.
  8. Any investment made based on recommendations in research reports are subject to market risks, and recommendations do not provide any assurance of returns. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report. Any reliance placed on the research report provided by the RA shall be as per the client's own judgement and assessment of the conclusions contained in the research report.
  9. The SEBI registration, Enlistment with RAASB, and NISM certification do not guarantee the performance of the RA or assure any returns to the client.
  10. For any grievances,
    • Step 1: the client should first contact the RA using the details on its website or following contact details:
      Customer care: [email protected]
      Grievance officer: [email protected], ATTN: Srikanth Meenakshi
      Compliance officer: [email protected], ATTN.: Bhavana Acharya
      Principal officer: [email protected], ATTN.: Vidya Bala
    • Step 2: If the resolution is unsatisfactory, the client can also lodge grievances through SEBI's SCORES platform at www.scores.sebi.gov.in
    • Step 3: The client may also consider the Online Dispute Resolution (ODR) through the Smart ODR portal at https://smartodr.in
  11. Clients are required to keep contact details, including email id and mobile number/s updated with the RA at all times.
  12. The RA shall never ask for the client’s login credentials and OTPs for the client’s Trading Account, Demat Account, and Bank Account. Never share such information with anyone including RA.

By browsing, viewing, using the Website and subscribing to the Research Services provided therein you consent to and agree to comply with these Terms and Conditions of subscription (“Terms”).

The RA reserves the right to change or modify the Website, the contents thereof and these Terms at any time. All modifications to these Terms & Conditions will be posted on the Website and will become effective immediately upon such posting. Changes once made will be communicated to the client. Continued use of the Website shall be construed as acceptance of the revisions to the Terms by conduct.

The following terms and conditions include but are not limited to minimum mandatory terms and conditions to clients as stipulated by SEBI.

1. Availing the research services

By accepting delivery of the research service, the client confirms that he/she has elected to subscribe to the research service of the RA at his/her sole discretion. The RA confirms that Research Services shall be rendered in accordance with the applicable provisions of the SEBI RA Regulations.

2. Obligations on RA

The RA shall be bound by the SEBI Act and all the applicable rules and regulations of SEBI, including the RA Regulations and relevant notifications of Government, as may be in force, from time to time.

3. Client Information and KYC

The client shall furnish all such details in full as may be required by the RA in its standard form with supporting details, if required, as may be made mandatory by Research Analyst Administration and Supervisory Body(RAASB)/SEBI from time to time. RA shall collect, store, upload and check KYC records of the clients with KYC Registration Agency (KRA) as specified by SEBI from time to time.

4. Standard Terms of Service

The consent of client shall be taken on the following understanding:

“I / We have read and understood the terms and conditions applicable to a research analyst as defined under regulation 2(1)(u) of the SEBI (Research Analyst) Regulations, 2014, including the fee structure.

I/We are subscribing to the research services for our own benefits and consumption, and any reliance placed on the research report provided by research analyst shall be as per our own judgement and assessment of the conclusions contained in the research report.

I/We understand that –

  1. Any investment made based on the recommendations in the research report are subject to market risk.
  2. Recommendations in the research report do not provide any assurance of returns.
  3. There is no recourse to claim any losses incurred on the investments made based on the recommendations in the research report.”

The declaration of the RA is as follows:

  1. We are duly registered with SEBI as an RA pursuant to the SEBI (Research Analysts) Regulations, 2014 and our registration details are: registration no SEBI INH200008653, with registration date 19th August, 2021
  2. We have the registration and qualifications required to render the services contemplated under the RA Regulations, and the same are valid and subsisting;
  3. Research analyst services provided by us do not conflict with or violate any provision of law, rule or regulation, contract, or other instrument to which it is a party or to which any of its property is or may be subject;
  4. The maximum fee that may be charged by the RA is ₹1.51 lakhs per annum per family of client. Our current fee structure, the term and duration of our subscription for our Research Services, can be viewed on our website here: https://primeinvestor.in/prime-pricing
  5. The recommendations provided by us as part of the Research Services do not provide any assurance of returns.

5. Consideration and mode of payment

The client shall duly pay to the RA the agreed fees for the services that RA renders to the client and statutory charges, as applicable. Such fees and statutory charges shall be payable through the specified manner and mode(s)/ mechanism(s).

The payment of fees shall be through a mode that shows traceability of funds. Such modes include but are not limited to credit cards/debit cards/ UPI/ net banking or any other mode specified by SEBI from time to time. However, the fees shall not be in cash.

6. Risk factors

  1. Investments are subject to market risk. Investing or trading in financial products involves risk. Past performance of the recommendation is not an indication of future returns. Past performance of the RA is not an indicator of future performance. Past performance of the security is not an indication of future returns.
  2. There are no assurances or guarantees that the objectives of any investment in financial products will be achieved.
  3. The names of financial products mentioned herein do not in any manner indicate their prospects or returns. The performance in the equity may be adversely affected by the performance of individual companies, changes in the market place and industry specific and macro-economic factors.
  4. The performance of the investments/ products recommended by the RA are subject to a wide range of risks, including but not limited to: performance of the respective companies, changes in equity and debt market conditions, micro and macro factors and forces affecting equity and debt markets, general levels of interest rates and interest rate risk, credit risk, liquidity risk, reinvestment risk, economic slowdown, volatility & illiquidity of the stocks, risks associated with trading volumes, liquidity and settlement systems in equity and debt markets and/or such other circumstance beyond the control of the RA or any of its Associates.
  5. Other risk factors include that may affect the performance of the investments/ products recommended by the RA include but are not limited to economic policies, changes of Government and its policies, acts of God, acts of war, civil disturbance, sovereign action and /or such other acts/ circumstance beyond the control of the RA or any of its Associates.
  6. The recommendations provided by the RA as part of its Research Services may not be suitable to all categories of investors.
  7. The client should read all scheme and security related documents carefully before investing.
  8. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

7. Conflict of interest

The RA shall adhere to the applicable regulations/ circulars/directions specified by SEBI from time to time in relation to disclosure and mitigation of any actual or potential conflict of interest. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

General disclosures: PrimeInvestor Financial Research Pvt Ltd (with brand name PrimeInvestor) is an independent research entity offering research services on personal finance products to customers. We are a SEBI registered Research Analyst (Registration: INH200008653). PrimeInvestor Financial Research Pvt. Ltd., its employees, directors or agents, do not have any material adverse disciplinary history as on the date of publication of this report.

Restrictions on trading: To ensure no conflict of interest, the RA declares as follows:

  1. Personal trading activities of the individuals employed as research analysts shall be monitored, recorded and subject to a formal approval by the directors or compliance officer of PrimeInvestor Financial Research Private Limited.
  2. Research analysts employed by PrimeInvestor Financial Research Private Limited or their associates or relatives shall not:
    • Deal/ trade in stocks recommended/ tracked by the research analyst within 30 days before and five days after the publication of a research report;
    • Deal/ trade in securities that the research analyst reviews in a manner contrary to the given recommendation;
    • Purchase or receive securities of the issuer before the issuer's initial public offering, if the issuer is principally engaged in the same types of business as companies that the research analyst follows or recommends.

Disclosures with respect to Research and Recommendations Services:

  1. The RA or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation.
  2. The RA, or any of its officers, directors, employees, or subsidiaries have not received any compensation/ benefits whether monetary or in kind, from the AMC, company, government, bank or any other product manufacturer or third party, whose products are the subject of its Research Services or investment information.
  3. The Research Analysts who have prepared the research reports that form part of the Research Services (“Research Analyst”) certify that all of the views expressed in the research report accurately reflect their views about the subject company or subject security.
  4. The RA or directors or employees or Research Analyst certify that no part of their compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report.
  5. The Research Analyst has not served as director, officer or employee in the subject company, AMC or insurance company of the mutual fund or insurance policy that is the subject of this report, or company whose bonds, NCDs, fixed deposits or other savings products that is the subject of this report.
  6. The Research Analyst or their relatives do not have any known direct or indirect material conflict of interest including long/short positions in the subject company.
  7. The Research Analyst may hold investments in the stocks, mutual fund schemes, bonds, fixed deposits, insurance policies, or other products that are the subject of the recommendations provided as part of the Research Services. The Research Analyst certifies that they will not act in a manner contrary to their views on these securities except in the event of significant news or event or change in personal financial circumstances and without formal approval from the directors of PrimeInvestor Financial Research Pvt. Ltd. or the compliance officer.
  8. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of the Research Services. Such conflict of interest shall be disclosed to the client as and when they arise.
  9. The RA or its directors or its employee or its associates have not managed or co-managed the public offering of any company. The RA or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. The RA or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. The RA or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation.
  10. The subject company of its research recommendations was not a client of the RA or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided.
  11. The RA or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.

PrimeInvestor Financial Research Pvt. Ltd., its Associates, the Research Analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies)? – NO

8. Termination of service and refund of fees:

The RA may terminate or suspend rendering of Research Services to the client in the following circumstances:

  1. On account of suspension/cancellation of registration of RA by SEBI. In case of suspension of certificate of registration of the RA for more than 60 (sixty) days or cancellation of the RA registration, RA shall refund the fees, on a pro rata basis for the period from the effective date of cancellation/ suspension to end of the client’s subscription period.
  2. The RA voluntarily chooses to terminate its Research Service. In the event of such termination of the Research Service, the RA shall refund the fees, on a pro rata basis for the period from the date of such termination of research service to end of the client’s subscription period.

9. Grievance redressal and dispute resolution:

Any grievance related to:

  1. nonreceipt of research report, or
  2. missing pages or inability to download the entire report, or
  3. any other deficiency in the research services provided by RA

shall be escalated promptly by the client to the person/employee designated by RA, in this behalf as under:

Name: Bhavana Acharya
Designation: Director & Compliance Officer, PrimeInvestor Financial Research Pvt Ltd
Email: [email protected]

The RA shall be responsible to resolve grievances within 7 (seven) business working days or such timelines as may be specified by SEBI under the RA Regulations.

RA shall redress grievances of the client in a timely and transparent manner. Any dispute between the RA and his client may be resolved through arbitration or through any other modes or mechanism as specified by SEBI from time to time.

If the client is not satisfied with the response of the RA, he/she can lodge his/her grievances with SEBI at scores.sebi.gov.in. Alternatively, the client may also write to any of the offices of SEBI. For any queries, feedback or assistance, please contact SEBI Office on Toll Free Helpline at 1800 22 7575 / 1800 266 7575

Details on grievances are available on the Website as follows: https://primeinvestor.in/ra-grievance/

10. Additional clauses:

Scope of the Research Service: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Services are not meant to be tailor-made or customized solutions that specifically apply to each client based on his/her risk profile.

The RA never guarantees the returns on the recommendation provided. Investor shall take note that investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The RA shall not be responsible for any loss to the Investors.

This service is not directed for access or use by anyone in a country, especially the USA, Canada or the European Union countries, where such use or access is unlawful or which may subject PrimeInvestor Financial Research Pvt Ltd or its affiliates to any registration or licensing requirement.

The Research Service, including recommendations, research reports, updates, and other information will be accessible through the RA’s website https://primeinvestor.in only. Such recommendations and updates will not be provided over phone calls.

Fees: Our current fee structure, the term and duration of our subscription for our Research Service, can be viewed on our website: https://primeinvestor.in/prime-pricing. Eligibility for any discounts is ascertained at the time the client subscribes. Any such discount and its tenure shall be at the discretion of the RA.

Subscription and access to content services fall under the purview of Goods and Services Tax (GST) as per the current indirect taxation policy, Government of India. Unless otherwise indicated, prices stated on our website are exclusive of applicable GST, any applicable value added tax (VAT) or other sales taxes. We are a business-to-consumer (B2C) service provider and we do not commit to provide any input tax credit on GST charged on subscription to our Research Service.

We may change the Subscription Fees and charges then in effect, or add new fees or charges which will take effect at the end of the client’s subscription period, by giving notice in advance and an opportunity to cancel renewal of the subscription.

Subscription Access & Renewal: Subscription to the Website commences immediately on the realisation of payment of the Subscription Fees. Subscriptions are set to be renewed automatically at the end of the subscription period.

Unless the client notifies us before the end of his/her subscription period, or the client cancels the auto-renewal mandate within the period specified by law, that the client does not wish to renew his/her subscription, the client’s subscription will renew for the period defined by the client’s subscription plan. We will charge the subscription using the same payment method that you previously used.

Although the client may notify to us his/her intention to his/her subscription, such notice will only take effect at the end of his/her then current subscription period, and he/she will not receive a refund other than as set out under Clause 8 in these Terms.

The client may notify us of his/her wish to cancel his/her subscription by sending an email to [email protected]. The client must provide at least 5 business days advance notice for this to be implemented.

Refunds: There can be no cancellation and refund of subscription fee paid once the subscription is active, other than as stated in Clause 8 of these Terms. If the client is entitled to a refund as specified under Clause 8 of these Terms, the RA will credit that refund to the card or other payment method used by the client to submit payment, unless it has expired - in which case the RA will contact the client to proceed with the refund. If we do issue a refund or credit due to circumstances outside the obligations specified under Clause 8, we are under no obligation to issue the same or a similar refund in the future.

General disclaimers: The recommendations made herein in the Research Services are expression of views and/or opinions and should not be deemed or construed to be advice for the purpose of purchase or sale of any security, nor a solicitation or offering on any investment/ trading opportunity on behalf of the company, AMC, insurance company, or issuer of security referred to herein.

The content and research reports generated by the RA does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities.

The information/ opinion/ views mentioned in research reports or by the RA are not meant to serve as a professional guide to the client or recipients of this Report. The research report, recommendation, or any other content published by the RA do not assure or guarantee any minimum or fixed returns to the client or recipients of the reports/ recommendations/ content.

Use of this information is at the client’s own risk. The client must make his/ her own investment decisions based on his/her specific investment objective and financial position and using such independent advisors as he/she believes necessary. The services rendered by the RA are on a best-effort basis. All information in the content or research report of the RA is provided on an as is basis. Information is believed to be reliable but the RA does not warrant its completeness or accuracy and expressly disclaim all warranties and conditions of any kind, whether express or implied.

While due care has been taken to ensure that the disclosures, information, and opinions given are fair and reasonable, PrimeInvestor Financial Research Pvt Ltd and/or none of its officers, directors, partners, employees, agents, subsidiaries, affiliates or business associates shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information/ opinions/ views contained in the research report and recommendations that form part of the Research Service, and/or mails, social media or notifications issued by PrimeInvestor Financial Research Pvt Ltd or any other agency appointed/authorised by PrimeInvestor Financial Research Pvt Ltd. Returns and performance figures mentioned in the research report represent past performance and should not be constituted to be future returns or guaranteed returns.

Any agreements, transactions or other arrangements made between the client and any third party named on (or linked to from) the Website are at your own responsibility and entered into at your own risk. Any information that you receive via the Website, whether or not it is classified as “real time”, may have stopped being current by the time it reaches you. Market price information may be rounded up/down and therefore may not be entirely accurate.

The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research Services before onboarding.

History, present business and background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services.

Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made thereunder against the Research Analyst relating to Research Analyst services.

Details of the RA's associates: No associates.

Usage of Website Content: This Website is controlled and operated by the RA. All material, including research reports, recommendations, portfolios, ratings, lists of financial products, illustrations, statements, opinions, views, photographs, products, images, artwork, designs, text, graphics, logos, button icons, images, audio and video clips and software (collectively, “Content”) are protected by copyrights, trademarks and other intellectual property rights that are owned and controlled by the RA or by other parties that have licensed their material to us.

Except where otherwise agreed in writing with the RA, material on the Website is solely for the client’s personal, non-commercial use. Except as provided below, the client must not copy, reproduce, republish, upload, post, transmit or distribute such material in any way, including by e-mail or other electronic means and whether directly or indirectly and the client must not assist any other person to do so.

Without the prior written consent of the RA, modification of the materials, use of the materials on any other web site or networked computer environment or use of the materials for any purpose other than personal, non-commercial use is a violation of the copyrights, trademarks and other proprietary rights, and is prohibited. Any use for which the client receives any remuneration, whether in money or otherwise, is a commercial use for the purposes of these Terms.

The client may occasionally distribute a copy of a research report, or a portion of the same, from the Website in non-electronic form to a few individuals without charge, provided the client includes all copyright and other proprietary rights notices in the same form in which the notices appear, original source attribution, and the phrase “Used with permission from PrimeInvestor Financial Research Pvt. Ltd.”

While the client may occasionally download and store research reports or information from the Website for his/her personal use, he/she may not otherwise provide others with access to the same. The foregoing does not apply to any sharing functionality we provide through the Website that expressly allows the client to share Content or links to Content with others. In addition, the client may not use Content he/she has downloaded for personal use to develop or operate an automated trading system or for data or text mining.

The client agrees not to rearrange or modify the Content available through the Website. The client agrees not to display, post, frame, or scrape the Content for use on another website, app, blog, product or service, except as otherwise expressly permitted by these Terms. You agree not to create any derivative work based on or containing the research products and Content. The framing or scraping of or in-line linking to the Services or any Content contained thereon and/or the use of webcrawler, spidering or other automated means to access, copy, index, process and/or store any Content made available on or through the Services other than as expressly authorized by us is prohibited.

The client further agrees to abide by exclusionary protocols (e.g., Robots.txt, Automated Content Access Protocol (ACAP), etc.) that may be used in connection with the Research Services. The client may not access parts of the Research Services to which he/she is not authorized, or attempt to circumvent any restrictions imposed on your use or access of the Services.

As a general rule, the client may not use the Content, including without limitation, any Content made available through one of our RSS Feeds, in any commercial product or service, without our express written consent.

The client may not create apps, extensions, or other products and services that use our Content without our permission. The client may not aggregate or otherwise use our Content in a manner that could reasonably serve as a substitute for a subscription to the Website.

The client may not access or view the Services with the use of any scripts, extensions, or programs that alter the way the Services are displayed, rendered, or transmitted to you without our written consent.

The client agrees not to use the Services for any unlawful purpose. We reserve the right to terminate or restrict the client's access to the Website if, in our opinion, the client's use of the Services may violate any laws, regulations or rulings, infringe upon another person's rights or violate these Terms.

Prohibited content: The Website includes comments sections, blogs and other interactive features that allow interaction among clients and between clients and the RA. We call the information posted by or contributed by users “Contributed Content.” In the course of availing of the Research Services or uploading any post or comment on the Website, the client shall not post any Contributed Content that (i) contains nude, semi-nude, sexually suggestive photos, (ii) tends or is likely to abuse, harass, threaten, impersonate or intimidate other users of the Website and/or Research Services, (iii) is lascivious or appeals to the prurient interest or if its effect is such as to tend to deprave and corrupt persons who are likely to use or have access to the Website and/or Services, or (iv) otherwise violates, is prohibited or restricted by applicable law, rule or regulation, is offensive or illegal or violates the rights of, harms or threatens the safety of other users of the Website and/or Services (collectively “Prohibited Content”).

We reserve the right to cease to provide the client with the Research Services or access to the Website, or terminate your subscription, with immediate effect and without notice and liability, for violating these Terms, applicable law, rules or regulations and reserves the right to remove Prohibited Content which is in violation of these Terms, or is otherwise abusive, illegal or disruptive. The determination of whether any content constitutes Prohibited Content, violates these Terms, or is otherwise abusive illegal or disruptive, is subject to the sole determination of the Firm.

Changes to Research Services: We are constantly endeavouring to improve the quality of Research Services provided to our clients. Due to this, the form and nature of the Research Services provided may change from time to time without any prior notice to the client. We reserve the right to introduce and initiate new features, functionalities, components to the Website and/or Research Services and/or change, alter, modify, or discontinue existing ones without any prior notice to the client.

Warranty and liability disclaimer: The Website, Research Services, and all the materials and services, included on or otherwise made available to the client through this Website is provided by the RA on an “as is” and “as available” basis without any representation or warranties, express or implied except otherwise specified in writing. Without prejudice to the foregoing paragraph, the RA does not warrant that:

  • This Website and/or Research Services will be constantly available, or available at all;
  • The information on this Website or provided through the Research Services is complete, true, accurate or not misleading; or
  • The quality of any products, services, information, or other material that you obtain through the Website or Services will meet your expectations.

The RA, to the fullest extent permitted by law, disclaims all warranties, whether express or implied, including the warranty of merchantability, fitness for particular purpose and non-infringement. The RA makes no warranties about the accuracy, reliability, completeness, or timeliness of the Website, Research Services, Content, Contributed Content, Services, software, text, graphics and links.

The RA does not warrant that this Website, Research Services, information, content, materials, or any other material included on or otherwise made available to you through this Website, their servers, or electronic communication sent by the RA are free of viruses or other harmful components.

Nothing on this Website constitutes, or is meant to constitute, advice of any kind.

Indemnification: The client:

  1. Represents, warrants and covenants that no materials of any kind provided by him/her will:
    1. Violate, plagiarise, or infringe upon the rights of any third party, including copyright, trademark, privacy or other personal or proprietary rights; or
    2. Contain libellous, Prohibited Content or other unlawful material;
  2. Hereby agree to indemnify, defend and hold harmless the RA and all of the RA’s officers, directors, owners, agents, customers/clients, information providers, affiliates, licensors and licensees (collectively, the “Indemnified Parties”) from and against any and all liability and costs, including, without limitation, reasonable advocate’s fees, incurred by the Indemnified Parties in connection with any claim arising out of any breach by the client of these Terms or the foregoing representations, warranties and covenants. The client shall cooperate as fully as reasonably required in the defence of any such claim. The RA reserves the right, at its own expense, to assume the exclusive defence and control of any matter subject to indemnification by the client.

Applicable law: This Website, including the Content and Contributed Content and information contained herein, and the provision of Research Services shall be governed by the Securities and Exchange Board of India, laws of the Republic of India and the courts of Chennai, India which shall retain exclusive jurisdiction to entertain any proceedings in relation to any disputes arising out of the same. As such, the laws of India shall govern any transaction completed using this Website.

Information gathered and tracked: Information submitted or collected on the Website or pursuant to the use of the Services is stored in a database. Specifically, we store the username, name, e-mail address, contact number, as submitted or collected on our Website or through the provision of the Research Services. We may use such information to send out occasional promotional materials, including alerts on new Services available, or other promotional and marketing material relating to our clients and customers.

In accordance with the Information Technology Act 2000, the name and the details of the Grievance Officer at PrimeInvestor is provided below:

Mr. Srikanth Meenakshi
PrimeInvestor Financial Research Pvt. Ltd., Registered office: 659, 4th Avenue, D-Sector, Anna Nagar Western Extension, Chennai 600 101.
Email: [email protected]

11. Mandatory notice:

Clients shall be requested to go through Do’s and Don’ts while dealing with RA as specified in SEBI master circular no. SEBI/HO/MIRSD-POD-1/P/CIR/2024/49 dated May 21, 2024 or as may be specified by SEBI from time to time.

12. Optional Centralised Fee Collection Mechanism:

SEBI has operationalized a centralized fee collection mechanism for IA and RA. Under this mechanism, clients shall pay fees to IAs/RAs through a designated platform/portal administered by a recognized Administration and Supervision body. This is an optional mechanism for the registered entities. At this time, PrimeInvestor has opted out of this fee collection mechanism. Therefore, all subscription payments for the Research Services will be through the modes as specified in Clause 5 of these Terms.

Enter the OTP sent to (Edit)
By doing this you agree to our terms & conditions
Didn't receive OTP? Resend

Have an account?
Login To Your Account
OR
Don’t have an account ? Register for free